Literature DB >> 7658585

Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.

C P Dinney1, R Fishbeck, R K Singh, B Eve, S Pathak, N Brown, B Xie, D Fan, C D Bucana, I J Fidler.   

Abstract

PURPOSE: These studies were designed to develop an orthotopic model for human bladder cancer and to isolate variant metastatic cell lines.
MATERIALS AND METHODS: The human bladder cancer cell line 253J was implanted into the muscular wall of the bladder of athymic nude mice. By in vivo recycling, we selected for 2 variant cell lines: 253J B-V, a bladder line isolated after 5 serial passages in the bladder, and 253J lung-IV, established from a lung tumor nodule that was recycled through the bladder.
RESULTS: These 2 cell lines showed enhanced tumorigenicity, as measured by a decreased latent period, and rapid growth as compared with the parental cell line. Moreover, orthotopic implantation of these cell lines resulted in metastasis to the lungs. These in vivo-selected, metastatic cell lines exhibited unique karyotypic alterations, increased anchorage-independent growth, overexpression of basic fibroblast growth factor, altered expression of adhesion molecules and the ability to migrate through Matrigel.
CONCLUSIONS: This reproducible model of human bladder cancer offers the opportunity to study cellular properties associated with tumor progression and metastasis and is suitable for the evaluation of new therapeutic strategies for invasive bladder cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7658585

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  62 in total

1.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

Authors:  C J Bruns; M T Harbison; H Kuniyasu; I Eue; I J Fidler
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Template-driven gene selection procedure.

Authors:  N Knowlton; I Dozmorov; K D Kyker; R Saban; C Cadwell; M B Centola; R E Hurst
Journal:  Syst Biol (Stevenage)       Date:  2006-01

3.  Metastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice.

Authors:  A Opolski; J Wietrzyk; D Duś; C Kieda; A Matejuk; A Makowska; E Wojdat; M Ugorski; A Laskowska; A Kłopocki; J Rygaard; C Radzikowski
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

4.  An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.

Authors:  Moo Rim Kang; Glen Yang; Klaus Charisse; Hila Epstein-Barash; Muthiah Manoharan; Long-Cheng Li
Journal:  J Vis Exp       Date:  2012-07-28       Impact factor: 1.355

5.  Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.

Authors:  Said Akli; Xin-Qiao Zhang; Jolanta Bondaruk; Susan L Tucker; P Bogdan Czerniak; William F Benedict; Khandan Keyomarsi
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

6.  p63 expression correlates with sensitivity to the Eg5 inhibitor ZD4877 in bladder cancer cells.

Authors:  Lauren Marquis; Mai Tran; Woonyoung Choi; I-Ling Lee; Dennis Huszar; Arlene Siefker-Radtke; Colin Dinney; David J McConkey
Journal:  Cancer Biol Ther       Date:  2012-05-01       Impact factor: 4.742

7.  Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer.

Authors:  Kilian M Gust; David J McConkey; Shannon Awrey; Paul K Hegarty; Jing Qing; Jolanta Bondaruk; Avi Ashkenazi; Bogdan Czerniak; Colin P Dinney; Peter C Black
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

Review 8.  1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.

Authors:  Yingyu Ma; Qiang Hu; Wei Luo; Rachel N Pratt; Sean T Glenn; Song Liu; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-26       Impact factor: 4.292

9.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

10.  1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.

Authors:  Teruo Inamoto; Sabitha Papineni; Sudhakar Chintharlapalli; Sung-Dae Cho; Stephen Safe; Ashish M Kamat
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.